Latest News

Northwell’s Staten Island University Hospital Performs First U.S. Procedure With New BioHealx Device for Complex Anal Fistulas STATEN ISLAND, N.Y.–(BUSINESS WIRE)–Northwell’s Staten Island University Hospital (SIUH) is the first medical center in the United States to perform surgery using the

GALWAY, Ireland--(BUSINESS WIRE)--Signum Surgical, a medical technology company dedicated to advancing the treatment of colorectal diseases, today announced the publication of first-in-human clinical data for its BioHealx® Anal Fistula Device in the International Journal of Colorectal Disease. The results support

Signum Surgical, (‘Signum’ or ‘the Company’) the medical technology company developing innovative solutions to treat colorectal diseases, is pleased to announce the appointment of Ms. Carol Burns as Chief Executive Officer.

Signum Surgical (‘Signum’ or ‘the Company’), a medical technology company developing innovative solutions to treat colorectal diseases, is pleased to announce that its BioHealxTM technology has been granted marketing clearance by the U.S. Food and Drug Administration (FDA), as a